📢 PRESS RELEASE 📢 ARCHIMED MedTech - the MedTech team of global private equity healthcare specialist #ARCHIMED - sells orthopedic implants maker Citieffe to leading global manufacturer of medical devices, Poly Medicure. Citieffe was the last investment in ARCHIMED’s MED I fund, now fully liquidated. MED I generated x7.2 investors’ money, or a 59% annual return over 11 years - the best performance of any 2014-vintage buyout fund. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/d8QkaBsF #ARCHIMED #ARCHIMEDMedTech #ImpactingHealthcare #Citieffe
ARCHIMED
Directeurs du capital-risque et du capital-investissement
Lyon, Auvergne-Rhone-Alpes 38 530 abonnés
Impacting Healthcare
À propos
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.
- Site web
-
http://www.archimed.group
Lien externe pour ARCHIMED
- Secteur
- Directeurs du capital-risque et du capital-investissement
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Lyon, Auvergne-Rhone-Alpes
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2014
- Domaines
- Diagnostics, Consumer Health, Pharma Services, Biopharma Products, MedTech, Healthcare IT, Life Science Tools et Biologic Services
Lieux
-
Principal
Obtenir l’itinéraire
9 rue des Cuirassiers
69003 Lyon, Auvergne-Rhone-Alpes, FR
-
Obtenir l’itinéraire
152 W 57th St
59/F
10019 New York, US
Employés chez ARCHIMED
-
Wendy White
Independent Board Director, CEO, Private Equity Strategic Advisor, Rare Disease, Woman's Health, Medical Device
-
Van Crocker
-
Markus Sandmayr
Directeur non executive// Business Humanizer & Partner @ InnateMotion for Business Growth with positive impact
-
Berthold Hackl
Healthcare & Life Sciences: Strategy and Transactions
Nouvelles
-
📈 Major milestone for Arkstone reached in October 2025📈 ARCHIMED's company announced it has supported doctors in making treatment decisions for over one million patients globally. This milestone underscores Arkstone’s leadership in Machine Learning (ML) and Generative Artificial Intelligence (gen AI)-driven infectious disease clinical guidance. https://lnkd.in/dqK2BRmK #ARCHIMED #ImpactingHealthcare #ARCHIMEDDiagnostics #ARCHIMEDHealthcareIT #Arkstone #PrescribeResponsibly #AntimicrobialResistance #AntimicrobialStewardship
-
-
📢 PRESS RELEASE 📢 #ARCHIMED Diagnostics - the Diagnostics team of global private equity healthcare specialist #ARCHIMED - closes the acquisition of California-based ARK Diagnostics, Inc., a global leader in disease and drug monitoring & detection. The transaction was completed through a carve-out from listed South Korean specialty chemical company, soulbrain holdings co., ltd., who retains a significant minority stake in ARK Diagnostics, Inc. ARK Diagnostics, Inc. is ARCHIMED Diagnostics’ third investment in 2025. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/eTtKG6FE #ARCHIMED #ARCHIMEDDiagnostics #ImpactingHealthcare #Diagnostics #ARKDiagnostics
-
-
📢 PRESS RELEASE 📢 #ARCHIMED FIM Medical announces the purchase of Vistec GmbH and becomes the leading developer and distributor of European occupational healthcare devices. FIM Medical offers a diversified, technologically-advanced range of products in the fields of vision, hearing and respiratory care. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/dj89MU7z #ARCHIMED #FIMMedical #ImpactingHealthcare #MedTech #Innovation
-
-
📢 PRESS RELEASE 📢 #ARCHIMED MedTech announces the acquisition of Global Dental Technology Platform, ZimVie, in a take-private deal. ARCHIMED MedTech is the team of private equity healthcare specialist ARCHIMED focused on the MedTech sector. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/dDBT4DKh #ARCHIMED #ARCHIMEDMedTech #ImpactingHealthcare #ZimVie #MedTech #Dental
-
-
📢 PRESS RELEASE 📢 #ARCHIMED buys Danish leading developer and manufacturer of skincare products DermaPharm A/S. DermaPharm is a major player in Nordic suncare and a world-renowned skincare contract development & manufacturing organization for third parties. To read the full Press Release, please visit our hashtag #ARCHIMED website 👇 https://lnkd.in/dPTTfhY7 #ARCHIMED #ImpactingHealthcare #DermaPharm #Skincare #Suncare #ConsumerHealth
-
-
📢 PRESS RELEASE 📢 ARCHIMED acquires cell line development pioneer ExcellGene SA and sister company Magellan Biologics & Consulting to accelerate expansion into biosimilars and high-performance transfection solutions. Partnering with founders and management, #ARCHIMED aims to create a group covering gene transfer, cell line development and cell culture-based manufacturing for high-performance production of recombinant proteins, and other advanced therapeutics. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/gi-T5ASm #ARCHIMED #ImpactingHealthcare #ExcellGene #MagellanBiologics #Bioprocessing #Therapeutics
-
-
How does ARCHIMED drive innovation in the #MedTech space? Episode 1 of our Coffee Chat with Former CEOs is now live! Brian Smith, former CEO of Ad-Tech Medical Instrument Corporation, shares how #ARCHIMED’s strategy, unique perspective, and focus on innovation helped the company grow and achieve a 5x return on investment. 👉 Watch the full episode to discover the Behind the Scenes of this successful partnership on our website. https://lnkd.in/diivKArF #ARCHIMED #ImpactingHealthcare #MedTech #Ad-Tech
-
📢 PRESS RELEASE 📢 ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products, expanding further its presence in the Consumer Health sector. To read the full Press Release, please visit our #ARCHIMED website 👇 https://lnkd.in/dJymZg4b #ARCHIMED #ImpactingHealthcare #Rivadis #ConsumerHealth #dermocosmetics
-
-
What drives a successful partnership with ARCHIMED? 🎬 Introducing “Coffee Chat with Former CEOs” - a video series where former CEOs of #ARCHIMED-backed companies share insights over a cup of coffee. From innovation to international expansion and exit, discover what made these partnerships thrive. => Episode 1 coming out soon - STAY TUNED. #ARCHIMED #ImpactingHealthcare #MedTech #AdTech #Bomi #IVD #Eurolyser